| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$259 |
February 2025 Rhyolite Ridge Mineral Resource Estimate
|
5 Mar 2025 9:42AM |
$0.145 |
$0.110 |
fallen by
24.14%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- 45% increase in Rhyolite Ridge South Basin Mineral Resource estimate
- Total of 510 million tonnes containing 3.97 million tonnes of lithium carbonate equivalent
- 14.66 million tonnes of boric acid equivalent within the permitted Project boundary
- 81% of the Resource classified as Measured & Indicated
- Three distinct production streams enhance flexibility
- Supports upcoming Ore Reserve estimate scheduled for April 2025
- New drilling included twelve drill holes from 2024
- Estimates based on improved geological models and reduced processing costs
- Ioneer can adjust production focus based on market conditions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$17 |
Request for suspension extension
|
5 Mar 2025 9:42AM |
$0.005 |
$0.008 |
risen by
60%
|
|
PGY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pilot Energy Limited seeks voluntary suspension extension until 5 April 2025.
- Extension is for the completion of the Offer for the Cliff Head project acquisition.
- The company is negotiating a capital raise with existing investors.
- Financial position negatively impacted due to suspension of oil production.
- Negotiations with TEG are critical to company viability.
- The capital raise amount is estimated between $7 million to $8 million.
- The Offer will proceed in two tranches, with shareholder approval needed for the second tranche.
- Pilot expects to conclude negotiations with TEG and finalize the Offer by 28 March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$17 |
RHY Investor Webinar
|
5 Mar 2025 9:40AM |
$0.093 |
$0.059 |
fallen by
36.56%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant progress on 2nd Generation ColoSTAT® Multiplex Alpha Kit.
- Delivery of 2nd Generation ColoSTAT® Beta Release candidate multiplex kits.
- Board renewal process commenced with new members joining.
- $3.2 million Research & Development Tax Incentive received.
- Completion of a $3.5 million placement.
- Acquisition of Genetype business assets enhances commercial growth.
- geneTypeTM product portfolio is now commercially available.
- ColoSTAT® anticipated commercial launch in 2H CY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Harvest Technology Group Ltd (HTG) ORDINARY FULLY PAID |
Information Technology |
$14 |
Proposed issue of securities - HTG
|
5 Mar 2025 9:39AM |
$0.016 |
$0.016 |
fallen by
0%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$3 |
Supplementary Prospectus
|
5 Mar 2025 9:36AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Supplementary prospectus dated 5 March 2025
- Offer Closing Date extended to 25 March 2025
- Record date is 6 March 2025
- Offer opens on 10 March 2025
- Rights trading ends on 18 March 2025
- New shares quoted from 19 March 2025
- Closing date for acceptances is 25 March 2025
- Announcement of Rights Issue results on 1 April 2025
- Normal trading of new shares expected on 2 April 2025
- Directors do not consider circumstances materially adverse
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$17,844 |
Notification of cessation of securities - COH
|
5 Mar 2025 9:36AM |
$260.710 |
$272.850 |
risen by
4.66%
|
|
| Motio Ltd (MXO) ORDINARY FULLY PAID |
Communication Services |
$10 |
Change of Director's Interest Notice
|
5 Mar 2025 9:36AM |
$0.027 |
$0.035 |
risen by
29.63%
|
|
| Impact Minerals Limited (IPT) ORDINARY FULLY PAID |
Materials |
$24 |
Update on the Renounceable Rights Issue to raise $5.2M
|
5 Mar 2025 9:35AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
IPT - Price-sensitive ASX Announcement
Full Release
Key Points
- Major Shareholder commits to subscribe for their full Entitlement
- Underwriting of the offer increased to $2 million
- Rights now trading on ASX under code ASX:IPTR
- Impact undertaking a 2 for 7 renounceable rights issue at $0.006 per share
- Eligible shareholders receive 1 free attaching new option for every 2 new shares
- Funds raised will support exploration and development projects
- Rights trading ends on March 14, 2025
- Rights Issue closes on March 21, 2025
- Encouragement for shareholders to participate in the capital raising
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GPT Group (GPT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$9,482 |
Change in substantial holding
|
5 Mar 2025 9:35AM |
$4.650 |
$4.950 |
risen by
6.45%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$3 |
Commencement of Rights Trading
|
5 Mar 2025 9:34AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$70 |
Becoming a substantial holder
|
5 Mar 2025 9:34AM |
$0.935 |
$0.640 |
fallen by
31.55%
|
|
| Triton Minerals Ltd (TON) ORDINARY FULLY PAID |
Materials |
$8 |
Suspension from Quotation
|
5 Mar 2025 9:33AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
TON - Price-sensitive ASX Announcement
Full Release
Key Points
- Triton Minerals Ltd requested a voluntary suspension of its securities.
- The suspension is effective immediately.
- The suspension is pending an announcement regarding a material transaction.
- The company is not aware of any reason why the suspension should not be granted.
- Trading will remain suspended until normal trading on 7 March 2025 or the announcement is made.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$11 |
Cancel - Application for quotation of securities - IVX
|
5 Mar 2025 9:32AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$135 |
Strong Progress in First Two Months of CY25 Achieved
|
5 Mar 2025 9:32AM |
$0.245 |
$0.210 |
fallen by
14.29%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- EchoSolv-AS now integrated and is in use at Beth Israel Deaconess Medical Centre.
- Launch of new study with Beth Israel to explore health economic benefit of early intervention.
- Additional four US hospital sites actively using EchoSolv-AS with another 60 sites earmarked for integration.
- Reimbursement presentation to CMS scheduled for May 2025.
- Appointment of Mr Sam Dribin as Chief Technology Officer.
- Multiple patents filed for EchoSolv-AS in key geographies.
- Fully funded pilot trial for medical device commenced in Australia and New Zealand.
- Ongoing discussions with strategic industry partners.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$22,416 |
Form 4 - Statement of Changes in Beneficial Ownership
|
5 Mar 2025 9:32AM |
$37.770 |
$38.520 |
risen by
1.99%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$22,416 |
Form 4 - Statement of Changes in Beneficial Ownership
|
5 Mar 2025 9:31AM |
$37.770 |
$38.520 |
risen by
1.99%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$6 |
Leliyn Graphite Bulk Concentrate Sample Dispatched
|
5 Mar 2025 9:31AM |
$0.120 |
$0.087 |
fallen by
27.50%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Bulk sample of Leliyn graphite concentrate dispatched for testing in Germany.
- Metallurgical tests will support economic studies and the estimation of an Indicated Resource.
- Kingsland is well-funded for the Leliyn Graphite Project.
- Strategic investment includes a binding offtake agreement on future production.
- Tests will aid in a Scoping Study for establishing mining operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$10 |
5EA Form 8-K - Meeting Results
|
5 Mar 2025 9:30AM |
$0.700 |
$0.645 |
fallen by
7.86%
|
|
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$3 |
R&D Tax Incentive advance received
|
5 Mar 2025 9:29AM |
$0.013 |
$0.003 |
fallen by
80.77%
|
|
1AD - Price-sensitive ASX Announcement
Full Release
Key Points
- $424,600 advance received under Radium Capital facility.
- Funds will support due diligence for three solid cancer immunotherapy products.
- AdAlta's 'East to West' strategy integrates Asian T cell therapy innovation with Australian manufacturing.
- Company focuses on differentiated T cell therapy products in solid cancers.
- The cellular immunotherapy market is expected to grow at a CAGR of 34% to $20.3 billion by 2028.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inventis Limited (IVT) ORDINARY FULLY PAID |
Industrials |
$1 |
Explanation of 1H25 Sales Results
|
5 Mar 2025 9:29AM |
$0.027 |
$0.010 |
fallen by
62.96%
|
|
IVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue for IVT decreased by 38% in 1H25 compared to 1H24.
- The company seeks investment funds for growth plans in the USA.
- Expected sales from potential government contracts in the Philippines exceed $60 million.
- The Furniture Division faces delays due to a national tender cycle.
- The Technology Division saw a 56% increase in sales year-over-year.
- Operational expenses reduced by 7% compared to the previous year.
- Significant rental cost savings achieved through relocation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$10 |
5EA Results of Meeting
|
5 Mar 2025 9:27AM |
$0.700 |
$0.645 |
fallen by
7.86%
|
|
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$31 |
Update - Application for quotation of securities - TMK
|
5 Mar 2025 9:27AM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
| Redcastle Resources Limited (RC1) ORDINARY FULLY PAID |
Materials |
$4 |
Additional High-Grade Gold Intersected in Eastern Goldfields
|
5 Mar 2025 9:27AM |
$0.009 |
$0.005 |
fallen by
44.44%
|
|
RC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gold grade intercepts at three key prospects confirm widespread mineralisation potential.
- 6,500m of RC drilling completed under budget, enabling expansion to 9,700m.
- QA results warrant initiation of a scoping study for potential open-pit development.
- Redcastle Reef and MCE offer promising satellite open-pit developments.
- Remaining drilling and assay results expected mid-April to support future growth plans.
- Drilling has confirmed lateral continuity of the Kestrel Lode at QA.
- High-grade intercepts include 4m @ 10.94 g/t Au and 7m @ 10.16 g/t Au.
- Maiden Mineral Resource Estimates expected for RR and confirmation of mineralisation at MCE.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,981 |
Response to ASX Aware Letter
|
5 Mar 2025 9:26AM |
$32.900 |
$29.040 |
fallen by
11.73%
|
|
GYG - Price-sensitive ASX Announcement
Full Release
Key Points
- GYG's earnings for 1H25 aligned with market expectations.
- GYG did not publish earnings guidance for the mentioned half-year period.
- Consensus estimates from sell-side analysts were utilized to gauge market expectations.
- Statutory earnings measures did not vary significantly from forecasts.
- GYG is in compliance with ASX Listing Rules.
- The response was authorized and approved by GYG's board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$5 |
Entitlement Offer Supplementary Prospectus
|
5 Mar 2025 9:26AM |
$0.068 |
$0.046 |
fallen by
32.35%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
